FI831740A7 - Menetelmä seskviterpeenilaktonipitoisen farmaseuttisen uutteen valmistamiseksi. - Google Patents

Menetelmä seskviterpeenilaktonipitoisen farmaseuttisen uutteen valmistamiseksi. Download PDF

Info

Publication number
FI831740A7
FI831740A7 FI831740A FI831740A FI831740A7 FI 831740 A7 FI831740 A7 FI 831740A7 FI 831740 A FI831740 A FI 831740A FI 831740 A FI831740 A FI 831740A FI 831740 A7 FI831740 A7 FI 831740A7
Authority
FI
Finland
Prior art keywords
preparing
extract containing
sesquiterpene lactones
containing sesquiterpene
pharmaceutical extract
Prior art date
Application number
FI831740A
Other languages
English (en)
Swedish (sv)
Other versions
FI831740A0 (fi
FI831740L (fi
Inventor
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26282867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI831740(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Publication of FI831740A0 publication Critical patent/FI831740A0/fi
Publication of FI831740A7 publication Critical patent/FI831740A7/fi
Publication of FI831740L publication Critical patent/FI831740L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI831740A 1982-05-19 1983-05-18 Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt FI831740L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8214572 1982-05-19
GB8227062 1982-09-22

Publications (3)

Publication Number Publication Date
FI831740A0 FI831740A0 (fi) 1983-05-18
FI831740A7 true FI831740A7 (fi) 1983-11-20
FI831740L FI831740L (fi) 1983-11-20

Family

ID=26282867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831740A FI831740L (fi) 1982-05-19 1983-05-18 Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt

Country Status (13)

Country Link
US (1) US4758433A (fi)
EP (1) EP0098041B1 (fi)
KR (1) KR840004511A (fi)
AR (1) AR230008A1 (fi)
AU (1) AU564371B2 (fi)
CA (1) CA1270843A (fi)
DE (1) DE3380306D1 (fi)
DK (1) DK219083A (fi)
FI (1) FI831740L (fi)
GB (1) GB2124486B (fi)
IE (1) IE55766B1 (fi)
NO (1) NO831762L (fi)
NZ (1) NZ204256A (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
MC2056A1 (fr) * 1987-12-23 1990-09-04 Psoricur Ltd Composition therapeutique contre le psoriasis,procede pour sa preparation et utilisation de plantes medicinales qu'elle contient
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
US5576329A (en) * 1992-07-24 1996-11-19 Hennessey; Richard K. Method for treating tendon or joint inflammation with papaverine HCL
US5278172A (en) * 1992-07-24 1994-01-11 Hennessey Richard K Method and composition for treating tendon or joint inflammation using a vasodilator
CN1056142C (zh) * 1993-01-04 2000-09-06 昆明医学院第一附属医院 水朝阳内酯的制备方法
CA2141126A1 (en) * 1995-01-26 1996-07-27 Natalie J. Lazarowych Combinational drug for treating migraine and other illnesses
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
JP4346685B2 (ja) 1996-10-21 2009-10-21 ユーロビタ アクティーゼルスカブ パルテニウム・インテグリフォリウム又はその部分若しくはそのエキス又はその成分を含有する医薬組成物、かかる植物材料の医薬製造のための使用、及びパルテニウム・インテグリフォリウムのエキスの製造方法
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
AU1573499A (en) * 1997-12-23 1999-07-19 Moser, Rene Sesquiterpene lactones specifically inhibit activation of nf-k B by preventing the degradation of IkB-alpha and IkB-beta
US6225339B1 (en) * 1998-01-29 2001-05-01 Pfizer Inc. Terpenoid lactone compounds and their production process
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
US6221899B1 (en) 1999-01-15 2001-04-24 Pfizer Inc. Terpenoid lactone compounds and their production process
IT1312342B1 (it) 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
PT1100516E (pt) 1999-06-03 2005-07-29 Johnson & Johnson Consumer Fr Extratos de matricaria (tanacetum parthenium) contra doencas inflamatorias
US6642243B1 (en) 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
DE10015617A1 (de) * 2000-03-29 2001-10-04 Peter Laetzsch Migränemittel
IN188857B (fi) * 2000-07-14 2002-11-16 Govind Kane Dr Shantaram
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
JP2004524335A (ja) * 2001-03-16 2004-08-12 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド フィーバーフュー抽出物を含む組成物およびその使用方法
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
EP2170324A4 (en) * 2007-06-21 2010-11-03 Puramed Bioscience Inc COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MIGRAINE HEADACHE AND ASSOCIATED SYMPTOMS
US10500182B2 (en) * 2018-01-10 2019-12-10 Robert Firger Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache
CN109761994B (zh) * 2019-02-28 2021-06-29 中国科学院新疆理化技术研究所 降碳类愈创木烷型倍半萜内酯类化合物及其制备方法

Also Published As

Publication number Publication date
FI831740A0 (fi) 1983-05-18
EP0098041B1 (en) 1989-08-02
CA1270843A (en) 1990-06-26
GB2124486A (en) 1984-02-22
US4758433A (en) 1988-07-19
GB2124486B (en) 1986-07-16
NZ204256A (en) 1988-02-29
EP0098041A3 (en) 1984-12-12
IE55766B1 (en) 1991-01-16
AU564371B2 (en) 1987-08-13
IE831164L (en) 1983-11-19
AU1464683A (en) 1983-11-24
DK219083D0 (da) 1983-05-17
DE3380306D1 (en) 1989-09-07
KR840004511A (ko) 1984-10-22
GB8313530D0 (en) 1983-06-22
EP0098041A2 (en) 1984-01-11
AR230008A1 (es) 1984-02-29
DK219083A (da) 1983-11-20
FI831740L (fi) 1983-11-20
NO831762L (no) 1983-11-21

Similar Documents

Publication Publication Date Title
FI831740A7 (fi) Menetelmä seskviterpeenilaktonipitoisen farmaseuttisen uutteen valmistamiseksi.
FI830776A7 (fi) Uudet yhdisteet, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkeaineena.
NL930032I2 (nl) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydronafyridine-3-carbozuren, werkwijzen ter bereiding ervan en deze bevattende geneesmiddelen.
ES508378A0 (es) Un metodo para la preparacion de un extracto de proteinas vegetales.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
IT1164216B (it) Procedimento per l'ottenimento di composti insaponificabili,a partire da sostanze naturali
ES519771A0 (es) Un metodo de producir una preparacion farmaceutica que contiene un derivado de sulfonil urea.
ES522789A0 (es) Un derivado de un alcohol b,v-dihidropoliprenilico.
FI821422A7 (fi) Menetelmä uuden farmaseuttisen tuotteen valmistamiseksi.
ES530391A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
FI872831A7 (fi) Menetelmä farmaseuttisten seosten valmistamiseksi.
ES523501A0 (es) "un metodo para preparar derivados de 3-metilflavona".
ES520759A0 (es) Un proceso de desoxigenacion.
ES507065A0 (es) Un metodo para preparar derivados de 2-oxoazetidina.
NL191562B (nl) Dibenzo [b,d] pyranderivaten, alsmede farmaceutische preparaten die een dergelijk derivaat bevatten.
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
FI834690A7 (fi) Menetelmä syövänvastaisten 14-asyloksi- 2'-haloantrasykliini-antibioottien valmistamiseksi.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
FI821535A7 (fi) Menetelmä titanaattien valmistamiseksi.
ES507939A0 (es) Un procedimiento de preparacion de nuevos derivados de la hidroxifenil-tetrahidropiridina .
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
FI821514A7 (fi) Menetelmä liikajännitteisyyttä vastustavien kromonijohdannaisten valmistamiseksi.
FI821515A7 (fi) Menetelmä kromonien valmistamiseksi.
FI823041A7 (fi) Farmaseuttisen yhdisteen valmistusmenetelmä.
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: R.P.SCHERER CORPORATION